InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,570.64
(
-0.89%
)
US TECH 100
19,045.60
(
-1.32%
)
Dow Jones
40,712.78
(
-0.43%
)
Brent Oil
76.75
(
0.20%
)
Bitcoin
60,640.44
(
0.44%
)
Post# of 252959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: mcbio post# 119059

Thursday, 04/28/2011 9:40:16 PM

Thursday, April 28, 2011 9:40:16 PM

Post# of 252959
You don't know for sure. However, in this case, primary endpoint is PFS rather than OS, and Nexavar data have been consistent in trials and real practice. I have been on the record saying I expect positive trial result from Tivozanib vs Nexavar, with or without this delay.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up